Legal Opinion

In Re Metoprolol Succinate Patent Lit.

United States Judicial Panel on Multidistrict Litigation

Decided August 9, 2004No. 1620, 1:04-80, 1:04-205, 4:03-592, 4:03-1169PublishedCited by 5 opinions

1Opinion of the Court

329 F.Supp.2d 1368 (2004)

In re METOPROLOL SUCCINATE PATENT LITIGATION

Astrazeneca AB, et al.

v.

Andrx Pharmaceuticals, LLC, et al., D. Delaware, C.A. No. 1:04-80

Astrazeneca AB, et al.,

v.

Eon Labs, Inc., D. Delaware, C.A. No. 1:04-205

Astrazeneca AB, et al.,

v.

KV Pharmaceutical Co., E.D. Missouri, C.A. No. 4:03-592

Astrazeneca AB, et al.,

v.

KV Pharmaceutical Co., E.D. Missouri, C.A. No. 4:03-1169

No. 1620, 1:04-80, 1:04-205, 4:03-592, 4:03-1169.

Judicial Panel on Multidistrict Litigation.

August 9, 2004.

Before WM. TERRELL HODGES, Chairman, JOHN F. KEENAN, D. LOWELL JENSEN, J. FREDERICK MOTZ, ROBERT L.…

2Cases cited1 opinion

  1. AstraZeneca AB v. Andrx Pharmaceuticals, LLCUnited States Judicial Panel on Multidistrict Litigation · 2004

3Cited by5 opinions

  1. In Re Brimonidine Patent LitigationUnited States Judicial Panel on Multidistrict Litigation · 2007
  2. In Re ALFUZOSIN HYDROCHLORIDE PATENT LITIGATIONUnited States Judicial Panel on Multidistrict Litigation · 2008
  3. Forest Laboratories Inc. v. Torrent Pharmaceuticals Ltd.United States Judicial Panel on Multidistrict Litigation · 2012
  4. In Re Desloratadine Patent LitigationUnited States Judicial Panel on Multidistrict Litigation · 2007
  5. In re Kerydin (Tavaborole) Topical Solution 5% Patent Litig.United States Judicial Panel on Multidistrict Litigation · 2019

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API